“The Impact of Tralokinumab on Quality of Life and School in Patients Aged 12–17 With Atopic Dermatitis: Results from the Phase 3 ECZTRA 6 Trial”. 2022. SKIN The Journal of Cutaneous Medicine 6 (6): s77. https://doi.org/10.25251/skin.6.supp.77.